Eligibility in a cohort of patients with hidradenitis suppurativa treated with bimekizumab: Lessons and pitfalls in a real-world setting

Artículo original

Año: 2024

Ureña-Paniego, C; Haselgruber, S; Soto-Moreno, A; Cuenca-Barrales, C; Arias-Santiago, S; Molina-Leyva, A

Título: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

• D1